Related Experiment Video
Updated: May 12, 2026
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
[Brachytherapy for cutaneous and lip carcinomas].
1Département de radiothérapie, institut Claudius-Regaud, 20-24, rue du Pont-Saint-Pierre, 31052 Toulouse cedex, France. delannes.martine@claudiusregaud.fr
Summary
Brachytherapy offers high local control rates with minimal complications for skin cancers like basal cell carcinoma and squamous cell carcinoma, especially for facial lesions. This treatment is a viable alternative when surgery is not ideal.
Area of Science:
- Oncology
- Dermatology
- Radiation Oncology
Context:
- Cutaneous basal cell carcinomas and squamous cell carcinomas are common skin malignancies.
- Prognosis is strongly linked to achieving local tumor control.
- Surgery is the primary treatment, aiming for complete resection without cosmetic or functional deficits.
Purpose:
- To evaluate brachytherapy as a treatment option for cutaneous skin cancers.
- To highlight its suitability for periorificial facial lesions.
- To compare low-dose-rate and high-dose-rate brachytherapy approaches.
Summary:
- Brachytherapy is an effective alternative for skin cancers when surgery is contraindicated or poses risks to cosmesis/function.
- It is particularly well-suited for periorificial facial lesions.
- Both low-dose-rate and high-dose-rate techniques achieve high local control rates with low complication rates.
Impact:
- Brachytherapy provides a valuable therapeutic option for skin cancer management, preserving function and cosmesis.
- It enables high success rates with minimal long-term side effects.
- Patient selection based on age, condition, lesion characteristics, and potential side effects is crucial for optimal outcomes.
